ICLR250417C370000
- 0.00
- 0.000.00%
Icon PLC Newsroom
Leerink Partners Maintains Icon PLC(ICLR.US) With Buy Rating, Maintains Target Price $235
TD Cowen Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $157
BofA Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $204
Icon Cut to Hold From Buy by TD Cowen
Icon Price Target Cut to $157.00/Share From $254.00 by TD Cowen
BofA Securities Cuts Price Target on ICON to $204 From $255
TD Cowen Downgrades ICON to Hold From Buy, Adjusts Price Target to $157 From $254
Barclays Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $165
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $208
Express News | ICON PLC : Truist Securities Cuts Target Price to $208 From $262
Barclays Downgrades Icon to Equal-Weight, Lowers Price Target to $165
Express News | ICON : Barclays Cuts to Equal-Weight From Overweight
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $200
Healthcare Stocks Aren't a Shelter From the Tariff Storm -- Barrons.com
Icon Is Maintained at Outperform by Mizuho
Trump Defends Tariffs, Announces Pharmaceutical Levies Coming Soon
Trending Industry Today: Charles River Leads Losses In CRO Stocks
Icon Price Target Cut to $215.00/Share From $290.00 by Citigroup
Express News | Citigroup Maintains Buy on Icon, Lowers Price Target to $215
Does ICON (NASDAQ:ICLR) Have A Healthy Balance Sheet?